GU Cancers 2020 | Chemo eligibility: bladder cancer

Srikala Sridhar

Srikala Sridhar, MD, MSc, FRCPC, Princess Margaret Hospital, Toronto, ON, Canada, discusses whether it is necessary to redefine cisplatin-ineligibility in metastatic urothelial cancer. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter